Searched for
QUADRIVALENT
India clears nationwide rollout of free HPV vaccine to curb cervical cancerIndia is launching a nationwide HPV vaccination program. This initiative aims to eliminate cervical cancer, a common threat to women. The v...
Why Indians skip the flu vaccine despite risksIn India, the quadrivalent influenza vaccine (QIV) faces low uptake due to limited awareness and high costs, despite being recommended for ...
Zydus launches vaccine for new strain of influenza virusZydus Lifesciences introduces India's first quadrivalent influenza vaccine, VaxiFlu-4, for protection against four new virus strains as per...
Dr Reddy's to promote, distribute Sanofi vaccine brands in IndiaThe announcement comes a day after Sanofi Healthcare India announced a separate partnership with Cipla to boost access to Sanofi's central ...
Cadila Pharma introduces vaccine for seasonal fluThe new vaccine targets four strains of the influenza virus subtype -A and B, responsible for seasonal epidemics, the drug firm said in a s...
COVID-19 vaccination must for inoculation against other diseases for Haj pilgrims, says Maharashtra civic bodyThose above the age of three years will be given the QMMV (Quadrivalent Meningococcal Meningitis Vaccine) and those above 65 will also be g...
Vaccine for cervical cancer prevention to be available in small quantity in 2023, increased next year, says Adar PoonawallaPoonawalla briefed Union Health Minister Mansukh Mandaviya about the HPV vaccine in the national capital.Speaking to after the meeting, the...
'Made in India' Cervical Cancer vaccine ready: Know the root causes and risks of the diseaseVaccine against cervical cancer has launched, and we bring associated risks and causes. Cervical cancer develops in the cells of the cervix...
'Indian' cervical cancer vaccine to hit market soonSingh said Covid-19 had raised awareness about preventive healthcare and the development of vaccines like the one against cervical cancer w...
India to soon get first vaccine against cervical cancerThe Serum Institute of India (SII) and the Department of Biotechnology(DBT) are set to launch India's first indigenously developed Quadriva...
All you need to know about the upcoming cervical cancer vaccine in IndiaTo obtain a complete regimen of HPV vaccines in India, one must spend at least Rs 5,000 to Rs 8,000. A qHPV vaccine is available from Merck...
DCGI recommends allowing SII to manufacture, stockpile qHPV vaccine against cervical cancer: SourcePrakash Kumar Singh, Director, Government and Regulatory Affairs at SII, had written to the Health Ministry on February 4 seeking approval ...
NTAGI to review trial data on SII's qHPV vaccine against cervical cancerSerum Institute of India Director for Government and Regulatory Affairs Prakash Kumar Singh applied to the Drugs Controller General of Indi...
SII seeks from DCGI market authorisation for India's first qHPV vaccine against cervical cancerIn the application to the Drugs Controller General of India (DCGI), Prakash Kumar Singh, director (government and regulatory affairs) at SI...
SII seeks govt's nod to manufacture, stockpile qHPV vaccine against cervical cancerThe Serum Institute of India has sought the government's permission to manufacture and stockpile indigenously developed Quadrivalent Human ...
GlaxoSmithKline Pharma Q2 results: Net profit declines 85% to Rs 76 crConsolidated revenue from operations of the company stood at Rs 879.32 crore for the quarter under consideration. It was Rs 882.02 crore fo...
Abbott launches quadrivalent vaccine for influenza in India"We are excited with the launch of the quadrivalent version of our flu vaccine, which can be offered to both children above six months and ...